Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
OliX Pharmaceuticals Expands Ocular Disease Pipeline; Adds OLX304A for the Treatment of Retinitis Pigmentosa 2019-05-10 09:24
1